ZEVALIN® » Learn about ZEVALIN | ZEVALIN® (ibritumomab tiuxetan)

ZEVALIN is a CD20-directed radiotherapeutic antibody administered as part of the ZEVALIN therapeutic regimen indicated for the treatment of patients with: Relapsed or refractory, low-grade or follicular B-cell non-Hodgkin's lymphoma (NHL). Previously